Abstract
Context
Zinc-biofortified staple crops offer a potentially cost-effective and sustainable approach to address zinc deficiency in low- and middle-income countries. Scientists have developed and released several zinc-biofortified staple crops varieties globally and assessed their efficacy in improving biomarkers of zinc status. However, there are inconsistencies in result across the studies.
Objective
The objective of the present research was to systematically explore the existing literature to assess the efficacy of zinc-biofortified staple crops in improving zinc status.
Data sources
We performed a comprehensive literature search using 5 electronic databases: SCOPUS, Medline, CINAHL, Embase, and Web of Science, focusing on randomized controlled trials reporting the efficacy of zinc-biofortified staple crops in improving zinc status. The initial search was conducted during April 14-16, 2024, with an updated search on April 8, 2025. The protocol was registered with PROSPERO (CRD42025603758).
Data extraction
In this review we identified 1869 articles from the 5 databases, with 1068 studies screened for title and abstract. Full-text review was conducted on 20 articles, and the 7 were ultimately included for this review based on eligibility.
Results
Among the 7 studies included in the review, only a crossover study reported an increase in plasma zinc at the midpoint, which was abolished at the endpoint. One study reported improvement in infection-related morbidity, while another reported increased hair zinc. Exploration of the included studies revealed several methodological issues, such as not adjusting plasma zinc for inflammation and ignoring loss of zinc during cooking, as well as overlooking the potential treatment effect of habitual intake of zinc and its bioavailability.
Conclusions
Plasma zinc concentration remains largely unaffected by consumption of biofortified staple crops. Further research addressing the abovementioned limitations are crucial to determine the efficacy of zinc-biofortified staple crops in improving the zinc status of populations.
Systematic Review Registration
PROSPERO registration No. CRD42025603758.
Keywords: trace minerals, nutrients, micronutrients
INTRODUCTION
Zinc deficiency (ZD) is a major micronutrient deficiency globally, with 17% of the world’s population at risk. The prevalence is notably higher in Asia (30%) and Africa (26%).1 Inadequate dietary intake is the primary cause of ZD among women and children living in low- and middle-income countries (LMICs) and is further compounded by the poor bioavailability of zinc in their habitual diet and their increased physiological demand.2 ZD can compromise physical growth, immune competence, reproductive functions, and neurocognitive development. Women entering pregnancy with inadequate zinc stores can experience adverse pregnancy outcomes and congenital malformations and are more likely to give birth to a child with low birth weight.3,4
Several intervention strategies exist to alleviate ZD in the population, but multiple challenges limit their applicability in LMICs. These include the expensive nature of the interventions and approaches requiring alteration of dietary habits, long-term commitment, or continuous monitoring for quality assurance.5 In contrast, biofortification of staple crops is a more feasible strategy for increasing the dietary intake of zinc and improving zinc status in LMICs. Biofortification can be achieved through the application of zinc-enriched fertilizer (agronomic), through the development of varieties, by conventional breeding or genetic modification, that can accumulate higher levels of zinc from soil, or through a combination of these techniques. Moreover, the biofortification of staple food does not require any alteration in dietary habits. This method is inexpensive, sustainable, requires only a one-time investment,6 and is well accepted when conventional breeding is applied.5 Furthermore, it is feasible for hard-to-reach areas, where the population relies on locally grown staples and diverse diets are unaffordable. To date, the HarvestPlus program and collaborators have developed and released several varieties of zinc-biofortified wheat and rice in many LMICs.7
Currently, population-level zinc status indicators include serum/plasma zinc concentration (SZC/PZC), dietary zinc intake, and the prevalence of stunting among children younger than 5 years, with PZC/SZC being the most reliable marker. In addition, functional markers used were linear growth, immune function, morbidity, and putative markers including hair/nail zinc concentration, and activity of zinc-dependent enzymes such as elongases and fatty acid desaturases 1 and 2 (FADS1 and FADS2). Several trials exploring efficacy or effectiveness of biofortified staples have been conducted in LMICs and reported inconsistently on some of these markers with diverse yet mostly null findings.
Although efficacy trials have reported inconsistent results, absorption studies with biofortified crops have revealed that these crops absorb a higher amount of zinc.8–13 Therefore, systematically exploration of the existing efficacy trials is critical for understanding the potential of this intervention approach. Unfortunately, a recent review on zinc-biofortified staple crops failed to incorporate the majority of efficacy trials and instead focused on compiling evidence from absorption studies involving zinc-biofortified crops.14 To address this knowledge gap, we have conducted this systematic review to determine the efficacy of zinc-biofortified staples in improving zinc status among different population groups.
METHODS
Study Selection
This systematic review was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Table S1).15 The review included studies reporting the efficacy or effectiveness of biofortified staple crops, such as rice, wheat, maize, and pearl millet, in improving zinc status. The acceptable markers for zinc status were either PZC or SZC or functional markers such as stunting/linear growth, immune function markers, immune status, history of morbidity, zinc intake, or proportion of ZD or other putative markers such as zinc-dependent enzyme activity and hair/nail zinc content. Zinc-biofortified staples were defined as crops biofortified during the process of growth through conventional breeding, agronomic activities, transgenic processes, or a combination of any. Studies that tested the efficacy or effectiveness of such crops against conventional or fortified conventional crops were considered. This review considered randomized controlled trials (RCTs) involving humans of any age group.
In this review we excluded animal, in vitro, and agricultural laboratory-based studies. Also excluded were studies that used fortified food or home-based fortification with multiple micronutrient powders as an intervention, or studies using any biofortified crops as a control arm, without any conventional crop as another control. Absorption studies measuring zinc absorption from biofortified crops or fortified food were also excluded if they did not report pre-post values of the zinc markers mentioned above among the study participants. Similarly, cross-sectional, case-control, and cohort studies were excluded, as were editorials, commentaries, case studies, and systematic or narrative reviews. The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) registration number CRD42025603758.16
Search Strategy
A comprehensive literature search was conducted in 5 electronic databases, SCOPUS (https://www-scopus-com.libraryproxy.griffith.edu.au/), Medline (Ovid: https://ovidsp-dc1-ovid-com.libraryproxy.griffith.edu.au/), CINAHL (EBSCO host: https://web-p-ebscohost-com.libraryproxy.griffith.edu.au/ehost/search), Embase (https://www-embase-com.libraryproxy.griffith.edu.au/search/), and Web of Science (https://www.webofscience.com/wos/woscc/basic-search) accessed through Griffith University Library. The search terms were designed under the following themes: population, intervention, control, outcome and study design (PICOS). The details are shown in Table 1. The search themes were rearranged to construct the following groups:
Table 1.
PICOS Criteria for Inclusion of Studies
| Parameter | Criterion |
|---|---|
| Population | Human (all age groups) |
| Intervention | Zinc-biofortified staple |
| Control | Conventional crop, Fortified conventional crop |
| Outcome | Plasma/serum zinc concentration, zinc deficiency, stunting or linear growth, morbidity, immune function/status, hair zinc/nail zinc, other potential biomarkers of zinc |
| Study design | Randomized Controlled Trials |
Zinc (zinc OR zinc* OR Zn),
Biofortification (biofortifi* OR “bio-fortifi*” or “bio fortifi*”)
Zinc status (plasma zinc concentration OR serum zinc concentration OR PZC OR SZC OR zinc intake OR zinc deficiency OR stunting OR immun* OR morbidity), and
Randomized controlled trial or efficacy trial or effectiveness trial (RCT OR efficacy study OR efficacy trial OR effectiveness study OR effectiveness trial).
For the RCT theme, a preformed search strategy specifically composed for use in SCOPUS was utilized and adapted for other databases.17 An initial literature search in all 5 databases was conducted between April 14-16, 2024, with an updated search conducted on April 8, 2025, to identify if any article was missing during the process of screening and preparing this manuscript. The detailed search terms and results are provided in Table S2. The results of the search have been reported using the PRISMA diagram shown in Figure 1.
Figure 1.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Flow Diagram of Article Selection for the Systematic Review.15
Data Extraction
After the literature search, the identified articles were exported from the database in the RIS format and imported to Covidence (https://covidence.org/). Duplicate articles were removed using the automated Covidence tool and manual checking. Title and abstract screening was conducted by P.M. based on eligibility criteria followed by full-text review by P.M. and S.K. In case of any conflict during the full-text review, a decision was made through a consensus-building process. The authors P.M. and S.K. discussed the reasons for the conflict, exchanged views, and re-evaluated studies. If the consensus still could not be reached, a third reviewer (F.A.) was involved in providing additional insights and a final decision. Once studies were identified for final inclusion, data extraction was carried out in a tabulated form that contained journal information (title, first author, year, and country of study), study characteristics (study participants, intervention crop and placebo crop, study duration, sample size, outcome measurements, statistical analysis, and adjustment of confounding variables), and study outcomes (PZC/SZC, prevalence of ZD, morbidity, immune function, linear growth expressed as prevalence of stunting or length-for-age z-score, zinc-dependent enzyme activity, and hair/nail zinc content). The study outcomes were reported as means and SDs, medians and IQRs, or proportions as appropriate.
Quality Assessment of the Studies
We used the “Jadad score” to assess the methodological quality of the RCTs included in this systematic review. The scoring system evaluated 3 key methodological features of clinical trials: randomization, blinding, and accountability of all patients, that is, withdrawal and dropouts.18 Each “yes” answer to each of the first 5 items scored 1 point, while each “yes” answer to either of the last 2 items deducted 1 point, resulting in an overall score of 0-5. Studies scoring more than 4 points were considered to be of high quality; studies scoring 3-4 points were considered to be of moderate quality; and those scoring less than 3 points were deemed low quality. In addition, the risk of bias assessment was conducted using a checklist based on the criteria proposed by Downs and Black. This scoring system evaluates 13 domains, assigning a score of 1 to each criterion satisfied and a score of 0 to each criterion not satisfied. The total score indicated the quality of the studies, with ≤ 4 indicating poor quality, 5-8 indicating intermediate quality, and ≥ 9 indicating good quality.19
RESULTS
Studies Included in the Review
In this review we identified 1869 articles from the 5 databases, of which 800 duplicates were removed by Covidence, and 1 duplicate was removed manually. The remaining 1068 studies were screened for titles and abstracts, of which, 1048 studies were found to be irrelevant. The remaining 20 studies underwent full-text reviews, and finally, 7 studies reporting the efficacy or effectiveness of zinc-biofortified staple crops were included in the analysis. (Figure 1).
Characteristics of the Included Studies
Table 2 presents the characteristics of the included studies. The 7 articles included in the analysis were reported from 5 independent trials, whereas 2 articles were nested20,21 in an effectiveness trial.22 The demographics of the study populations varied greatly among the studies. One study (14.3%) was conducted on preschool-aged children (12-36 months old),23 3 studies (42.9%) enrolled adolescent girls (8-15 years old),20–22 1 study (14.3%) included women of reproductive age (15-49 years old),24 1 study (14.3%) was on school-going children (less than 12 years old)25 and 1 study (14.3%) recruited mother-child pairs.26 Biofortified wheat was the most common intervention material used in the included studies, with 6 out of 7 studies (85.7%) using biofortified wheat20–22,24–26 and 1 study (14.3%) used biofortified rice.23 All of the studies used conventional crops as controls except for the study by Signorell et al.,25 who conducted a 3-arm RCT with post-harvest–fortified wheat flour as well as conventional wheat flour as the other arms. Apart from the Signorell et al.25 study, all of the studies delivered their interventions at the household level, whereas the abovementioned study delivered them at the school.25 The crossover trial conducted by Lowe et al.24 had the shortest intervention duration of 8 weeks whereas Signorell et al.11 continued their intervention for 5 months, Gupta et al.,22 Sazawal et al.,26Shahzad et al.,21 and Frederickson et al.20conducted their trials for 6 months, and Jongstra et al.23 had the longest intervention of 9 months.
Table 2.
Characteristics of the Included Studies
| First author, year, country | Population [sample size] | Crop type | Intervention [dosage] | Control [dosage] | Duration | Primary outcome | Secondary outcomes | Covariates |
|---|---|---|---|---|---|---|---|---|
| Sunil Sazawal, (2018)26, India | WCBA and child pair [6005] | Wheat flour | HZn wheat flour developed through foliar spraying of PBW 500 wheat variety [30 mg/kg] | LZn wheat flour from PBW 500 grown without foliar spraying [20 mg/kg] | 6 mo | PZC |
|
Sociodemographic variables (age, family type, HH type, safe water), Compliance, anthropometry (height, weight, waist circumference for WCBA), compliance |
| Nicola M. Lowe (2022)24, Pakistan | Women of reproductive age, age 16-49 y [50] | Wheat flour |
|
|
8 wk | PZC | Plasma selenium, plasma copper, plasma zinc-copper ratio, zinc-dependent enzyme activity (FADS1, FADS2, ELOVL5) | Sociodemographic variables (age, education, marital status, HH demography, housing materials, house ownership, WASH practice, meal preparation place), anthropometric measurements, mean nutrient intake, dietary diversity, hematological parameters (Hb, Hct, RBC count, MCV, MCHC), Compliance |
| Swarnim Gupta (2022)22, Pakistan | Adolescent girls aged 10-16 years [517] | Wheat flour |
|
|
25 wk | PZC | Prevalence of ZD, Serum iron, serum ferritin, STfR, ID, IDA, plasma copper, plasma selenium, copper: zinc ratio, CRP, AGP |
|
| Roelinda Jongstra (2022)23, Bangladesh | Children aged 12-36 mo [520] | Rice | BRRI-42 rice [28.5 ± 3.5 mg/kg (raw rice)] | BRRI-28 rice [14.7 ± 0.8 mg/kg] | 9 mo | PZC | ZD, iron deficiency (plasma ferritin), anemia (Hb conc), inflammation (CRP and AGP), anthropometry (wasting, stunting, underweight), Intestinal inflammation (plasma I-FABP, fecal Calprotectin, fecal pH, in sub-sample), fatty acid percentage, FADS activity (sub-sample), morbidity | Age, sex, mother’s age, education, religion, and household food insecurity, Ccompliance |
| Coralie Signorell, (2023)25, India | School going children aged <12 years [273] | Wheat flour |
|
|
20 wk | PZC | Inflammatory markers (AGP, CRP), Incidence of leukocyte DNA strand breaks (sub-sample), Anthropometry (weight, height, | Age, sex, Hb conc, compliance. |
| Christopher J. Frederickson (2023)20, Pakistan | Adolescent girls aged 10-16 years [123] | Wheat flour |
|
|
25 wk | Zinc content of hair | Sulfur content of hair, Zn-Sulfur ratio. | |
| Babar Shahzad (2024)21, Pakistan | Adolescent girls aged 10-16 years [398] | Wheat flour |
|
|
25 wk | Enzyme activity of Omega-6 FA desaturation | Plasma cholesterol, triglycerides, and fatty acids, Plasma oxylipins | Age, menarche status, BMI, CRP, AGP, and triglycerides |
Abbreviations: PZC, plasma zinc concentration; RDW, red cell distribution width; MCV, Mean corpuscular volume; MCH, Mean corpuscular haemoglobin; HH, household; FADS1 & 2 = Fatty Acid Desaturates 1 & 2; ELOVL5 = elongase; Hb, Haemoglobin; Hct, Haematocrit; ID, Iron deficiency; IDA, Iron deficiency anaemia; CRP, C-reactive protein; AGP, alpha-1 acid glycoprotein; MCHC, Mean corpuscular haemoglobin concentration; FeZn Pearl Millet, Pearl millet biofortified with both iron and zinc; MUAC, Mid upper arm circumference; BRRI, Bangladesh Rice Research Institute; I-FABP, Intestinal fatty acid binding protein; PBW 550 = A wheat variety developed by Punjab Wheat Board; FA, Fatty acid; RBC, red blood corpuscle; STfR, soluble transferrin receptor; WASH, water, sanitation, and hygiene; WCBA, women of child bearing age; ZD, zinc deficiency.
Except for 2 studies,20,21 all studies reported changes in PZC as an outcome indicator. In addition to PZC, the proportion of participants with ZD at baseline and endline was also reported in 2 studies.22,23 Given the importance of systematic inflammation with PZC, 3 studies included markers of systemic inflammation, such as C-reactive protein (CRP) and apha-1 acid glycoprotein (AGP) in their study.22,23,25 In 1 study the results of a nested RCT revealed hair zinc concentration (HZC), hair sulfur content, and hair Zn:S ratio,20
Several studies in this review also included putative or functional markers of the zinc status. Three studies used zinc-dependent enzyme activities such as fatty acid desaturate activities and other markers of lipid metabolism such as oxylipins,21,23,24 whereas Signorell et al.25 reported DNA strand breaks. Two studies reported functional markers of zinc, including morbidity and anthropometric indices.23,25
Except for the studies by Frederickson et al.20 and Shahzad et al.,21 all studies reported varying numbers of population characteristics, such as sociodemographic data, dietary intakes, status of other micronutrients, etc, that could have potentially confounded the treatment effect (Table 2). The studies by Lowe et al.24 and Gupta et al.22 included the highest number of such variables, while the study by Signorell et al.25 reported the least number of variables.
Adherence to the Study Protocol
All the included studies, except the studies by Frederickson et al.20 and Shahzad et al.21reported compliance with the study. However, their methods of monitoring varied greatly, as did adherence to the study diet among the study participants. All of the 5 independent studies reported compliance of 80% or higher. Table 3 shows the compliance, recording process, and zinc intake from the study diets reported by the included studies.
Table 3.
Compliance and Zinc Intake From Study Diet Reported in Included Studies
| First author, (year) | Methods of monitoring compliance | Compliance in intervention | Compliance in control | Crop consumption intervention | Crop consumption control | Zinc consumption in intervention | Zinc consumption in control | Difference in zinc intake |
|---|---|---|---|---|---|---|---|---|
| Sunil Sazawal, (2018)26 | Provided pictorial diary card and assessed adherence by collecting data on proportion of intervention consumed/d, portion size, and unused quantity recovered from households. Cards reviewed during wkly visit |
|
|
|||||
| Nicola M. Lowe (2022)24 | Provided flour for entire household, measured bi-wkly, leftover flour and No. of meals when study flour was not consumed |
|
224 gm/d flour (average) | 11.0 mg/d | 5.0 mg/d | 6.0 mg/d | ||
| Swarnim Gupta (2022)22 | Conducted spot checks to note if study flour was present, being consumed, and additional flour was purchased. Retrieved previous bags to ensure study flours were consumed. | Not compared between groups, but reported overall high compliance; 1923 of 1953 visits in 399 households, showed study flour used regularly | 405 gm/d flour (average) | 8.4 mg/d | 6.9 mg/d | 1.5 mg/d | ||
| Roelinda Jongstra (2022)23 | Delivered weighted portion of cooked rice only for study participants. Leftovers collected on next d to measure consumption | 80.3%c | 83.5%c |
|
|
2.22 ± 0.47 mg/d | 1.20 ± 0.34 mg/d | 1.0 mg/d |
| Coralie Signorell (2023)25 | Provided during school lunch, which was visually inspected and recorded by study team as partial, full or missing consumption. Consumption of 3 chapattis were considered as 100% compliance. | Did not report | 4.4 ± 1.6 mg/d |
|
1.8-3.3f mg/d | |||
| Christopher J. Frederickson (2023)20 | Not reported for the sub-sample included in the study from the main study by Gupta et al. 2022 | |||||||
| Babar Shahzad (2024)21 | Not reported for the sub-sample included in the study from the main study by Gupta et al. 2022 | |||||||
Abbreviations: AGP, alpha-1 acid glycoprotein; BRRI, Bangladesh Rice Research Institute; conc, concentration; CRP, C-reactive protein; ELOVL5, elongase; FA, fatty acid; FADS1 and 2, fatty acid desaturates 1 and 2; FeZn Pearl Millet, pearl millet biofortified with both iron and zinc; Hb, hemoglobin; Hct, hematocrit; HH, household; HZN, high zinc; ID, iron deficiency; IDA, iron deficiency anemia; I-FABP, intestinal fatty acid binding protein; LZN, low zinc; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MUAC, mid-upper arm circumference; PBW 550, wheat variety developed by Punjab Wheat Board; PZC, plasma zinc concentration; RBC, red blood corpuscle; RDW, red cell distribution width; STfR, soluble transferrin receptor; WASH, water, sanitation, and hygiene; WCBA, women of child bearing age; ZD, zinc deficiency.
Proportion of days when the participant consumed more than 50% of the allocated flour.
If consumed 100% of the allocated flour.
Compliance was calculated based on percentage of children consuming 80% of their total calculated study rice portion for total intervention time.
Kannada school.
English school.
Difference between biofortified wheat and control wheat.
Quality of the Selected Studies
According to the Jadad scale, the quality scores of the included studies ranged from 4 to 5 (Table 4). Two studies24,26 were rated as moderate quality (score 4), whereas the rest scored >4 and were considered high quality. However, the articles published by Frederickson et al.20 and Shahzad et al.21 were nested RCTs within the study conducted by Gupta et al.,22 and they did not elaborate on the methods of blinding, randomization, and drop-outs, but the full score was awarded to them on account of the detailed information provided by the parent trial.22 The risk of bias score of the included studies ranged from 11 to 13, showing that all the included studies were of good quality (Table 5).
Table 4.
Jadad Score of the Selected Articles
| Question | 1st Author (y) |
||||||
|---|---|---|---|---|---|---|---|
| Sazawal et al. (2018) 26 | Lowe et al. (2022) 24 | Gupta et al. (2022) 22 | Jongstra et al. (2022) 23 | Signorell et al. (2023) 25 | Frederickson et al. (2023) 20 | Shahzad et al. (2024) 21 | |
| Was study described as randomized (includes words such as randomly, random, and randomization)? | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Was method used to generate the sequence of randomization described and appropriate (table of random numbers, computer generated, etc)? | 1 | 1 | 1 | 1 | 1 | 1a | 1a |
| Was study described as double blind? | 1 | 1 | 1 | 1 | 1 | 1a | 1a |
| Was method of double blinding described and appropriate (identical placebo, active placebo, dummy etc | 1 | 0 | 1 | 1 | 1 | 1a | 1a |
| Was there a description of withdrawals and dropouts? | 0 | 1 | 1 | 1 | 1 | 1a | 1a |
| Deduct 1 point if methods used to generate sequence of randomization was described and was inappropriate (patients were allocated alternatively, or according to date of birth, hospital number, etc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deduct 1 point if study was described as double-blind but method of blinding was inappropriate (eg, comparison of tablet vs injection with no double dummy) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 | 5 |
Was not elaborately described in the paper, but the parent trial was referred to, which contained the detailed description.
Table 5.
Risk of Bias Score of the Included Articlesa
| Questions about included studies | Sazawal et al. (2018) 26 | Lowe et al. (2022) 24 | Gupta et al. (2022) 22 | Jongstra et al. (2022) 23 | Signorell et al. (2023) 25 | Frederickson et al. (2023) 20 | Shahzad et al. (2024) 21 |
|---|---|---|---|---|---|---|---|
| Are the hypothesis/aim/objective clearly described? | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Are main outcomes clearly described in introduction or methods section | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Are characteristics of the patients included in the study clearly described? | 1 | 1 | 1 | 1 | 1 | 1b | 1b |
| Are interventions of interest clearly described? | 1 | 1 | 1 | 1 | 1 | 1b | 1b |
| Are main findings clearly described? | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Are data for the main outcomes estimative of the random variability? | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Have actual probability values been reported for the main outcomes? | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Representativeness of the population included? | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
| Was blinding of study participants included? | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Is use of statistical test appropriate to evaluate the data? | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Were study particpants randomized to intervention groups? | 1 | 1 | 1 | 1 | 1 | 1b | 1b |
| Were adequate adjustments to interfering factors performed? | 0 | 1 | 1 | 1 | 0 | 1b | 1b |
| Is the presence of statistical power clearly described? | 1 | 1 | 1 | 1 | 1 | 0 | 1b |
| Total | 11 | 12 | 13 | 13 | 12 | 11 | 12 |
,19 Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384.
Was not elaborately described in the paper, but the parent trial was referred to, which contained the detailed description.
Outcomes
Plasma Zinc Concentration and Zinc Deficiency
All 5 studies that measured PZC failed to report a positive impact of the intervention on PZC from the baseline to endline. However, only 1 study, employing a cross-over design, reported a statistically significant, within-particpant difference in PZC between the control and intervention periods at midline (after 4 weeks), which was abolished at endline (after 8 weeks). The mean (SD) of difference at midpoint was 41.5 (109.7) μg/L [t = 2.42, (40df), P = .02]. However, this difference became insignificant at the endpoint [t = 0.77, (42df), P = .45].24
Further, Gupta et al.22 conducted a subgroup analysis among the participants with ZD at baseline but failed to demonstrate any significant difference in PZC between the intervention and control groups. Jongstra et al.23 reported that PZC decreased in both the intervention and control groups and this difference was predicted by time (P < .001), but not treatment (P = .276) or time-by-treatment (P = .282) in mixed-effect models (MEMs). However, neither study found a statistically significant difference between the intervention and the control groups.
Authors of 2 studies found that assessed the impact of intervention on the prevalence of ZD reported contrasting results. Jongstra et al.23 reported that the prevalence of ZD increased by 3.7% and 8.7% in the intervention and control arm, respectively, from baseline to endline. In contrast, Gupta et al.22 reported an overall reduction in ZD in both the intervention and control groups. However, neither study found a statistically significant difference between the intervention and control groups.
Morbidity
Morbidity, a functional outcome of zinc status, was reported by Sazawal et al.26 and Jongstra et al.23 Sazawal et al.26 reported that children in the high–zinc-biofortified wheat group had a 17% lower duration of pneumonia (relative risk [RR], 0.82; 95% CI, 0.68-0.99) and 39% lower duration of vomiting [RR= 0.60, 95% CI, 0.44-0.83] compared to the low-zinc wheat group. Among the women of childbearing age, there was a 9% reduction in days with fever (RR, 0.90; 95% CI, 0.82-0.98) in the high–zinc-biofortified wheat group. Jongstra et al.23 reported that there was no statistically significant difference in the longitudinal prevalence ratio (LPR) of fever, vomiting and diarrhea between the study arms. However, the LPR was significantly higher for the number of days with a cold, chest problems, or any (total) morbidity in the intervention arm.
Anthropometry
Given the role of zinc in child growth, Jongstra et al.23 reported anthropometry as a secondary outcome. The study found that the height-for-age z-score (HAZ) had significant time (P < .001) and time × treatment (P = .001) interactions in the MEM. No other anthropometric indicators showed any significant differences between the control and treatment groups from baseline to endline. Similarly, the prevalence of wasting, stunting, and underweight declined in both groups, without any impact of treatment.
Other Zinc Status Markers
Fatty Acid Concentrations and Desaturates Activity
Since zinc acts as a cofactor for fatty acid desaturates and elongase enzymes, 3 of our included studies measured plasma fatty acid concentrations and estimated the impact of zinc intervention on enzymes involved in essential fatty acid metabolism as a putative marker of zinc status.21,23,24 Jongstra et al.23 measured plasma fatty acid (FA) concentrations and reported them as a percentage of total FA. They reported that there were no significant time-by-treatment effects on any of the FA percentages or activity indices in MEM. On the other hand, Lowe et al.24 measured the within-particpant variation in the activity of FADS1, FADS2, and elongase (ELOVL5) in their crossover trial. They reported a marginal increase in FADS1 activity (P = .059) and a significant decrease in FADS2 activity (P < .001) at endline during the intervention period in 1 group. The same group exhibited significantly higher levels of ELOVL5 at midline (P = .044) and significantly lower levels of ELOVL5 at endline (P = .007) during the intervention period. Shahzad et al.21 reported no significant effects of intervention on any of the FA activity indices. Four pro-inflammatory oxylipins were reduced significantly over time, but the group × time interaction in response to the intervention was insignificant for all of them after the statistical correction of the false-discovery rate.
Leucocyte DNA Damage
Signorell et al.25 measured DNA single-strand breaks indicated by olive tail moments as a marker of zinc status in a subsample of their study population. These authors reported no significant group or time differences (P = .364). Moreover, DNA strand breaks did not correlate with PZCs (r = 0.004, P = .945).25
Hair Zinc Concentration
Frederickson et al.,20 in their nested randomized controlled trial, measured HZC, indicated by “zinc counts” in a single strand of hair using X-ray fluorescence (XRF) spectrometry in a subsample of adolescent women enrolled in the study conducted by Gupta et al.22 Frederickson et al. reported a significant increase in HZC at the end line in the intervention arm compared to the baseline, which was not observed in the control arm.20
DISCUSSION
To the best of our knowledge, this is the first reported review that has systematically explored the efficacy or effectiveness of zinc-biofortified staples in improving zinc status among high-risk groups. Overall, the consumption of zinc-biofortified staples did not affect PZC or the prevalence of ZD, as evidenced from the included studies. Additionally, there was very little effect reported on functional biomarkers, such as morbidity and growth, or on other putative markers, such as the activity of zinc-dependent enzymes involved in essential fatty acid metabolism, single-strand DNA damage, and hair zinc concentrations.
PZC is the most commonly used and reliable biomarker of zinc status in the population. However, it is affected by several factors other than dietary zinc intake, such as infection, food intake (fasting/nonfasting), and time of day.2 Among the included studies, only the studies by Jongstra et al.23 and Signorell et al.25 reported measuring PZC using fasting blood samples. Moreover, as plasma zinc is a negative acute-phase reactant, its concentration may decrease in the presence of inflammation, necessitating adjustment for subclinical infection.2 Two of our included studies, Lowe et al.24 and Sazawal et al.26 did not measure any marker of inflammation such as AGP or CRP, and, thus their reported values of PZC may have been biased by subclinical inflammation. Although randomization can help control for the potential confounders, including subclinical inflammation, it remains standard practice to measure inflammatory markers with an attempt to adjust for PZC.
PZC has also been known to respond to dietary intake, only at moderate or severe levels of zinc restriction, such as when zinc intake is <1 mg/d for 4-5 weeks or 3-5 mg/d continued for several months.2 Given that the difference in zinc intake from biofortified staples between the intervention and control groups was relatively small in our included studies (Table 3), and considering that PZC is tightly regulated by homeostatic mechanisms, it is likely that this small difference in dietary zinc was insufficient to produce a measurable change in PZC between groups. This lack of sensitivity of PZC to dietary interventions has led to limited recognition of the impact and rendered an unfavorable policy environment for inversing on direct and nutrition-sensitive interventions to alleviate ZD.
Growth, a functional biomarker of zinc status, was assessed by Jongstra et al. who reported a significant improvement in HAZ between the intervention and control groups from baseline to endline. It is noteworthy that the difference in zinc intake among intervention and control study participants was very small (∼1mg/d) and t Jongstra et al. did not report any difference in PZC.23 This result may be explained by the homeostatic mechanism of zinc metabolism whereby growth cessation is an early adaptive response to dietary zinc inadequacy in growing individuals that is aimed at preserving tissue zinc and maintaining zinc dependent physiological functions.27 This hypothesis is supported by evidence showing that zinc supplementation can lead to rapid catch-up growth in zinc-deficient children, without significant change in PZC.28–31 Given that 80% of the study population has ZD at baseline, the meager increase in zinc could have likely been utilized for growth among the children.
Other zinc status biomarkers that are more responsive to dietary zinc intake have been explored, and some of them have been reported in the included studies. Adequate zinc intake is required to support ω-6 fatty acid metabolism, especially the metabolism of linoleic acid (LA) to arachidonic acid (AA), where γ-linoleic acid (GLA) and di-homo γ-linoleic acid (DGLA) are intermediary substances.32,33 FADS2, elongase, and FADS1 mediate the conversion of LA to GLA, GLA to DGLA, and DGLA to AA, respectively.34–36 However, activities of zinc-dependent enzymes of essential fatty acid (EFA) metabolism (FADS1, FADS2, ELOVL5, etc) had not shown any marked difference between the intervention arm or control arm in any of the studies that reported them.21,23,24 Although Lowe et al.24 reported some differences between groups at different time points, the changes were not consistent. It is important to note that Lowe et al.24 collected nonfasting blood samples from their participants. Therefore, the results can be challenging to interpret because previous studies have reported an association between zinc status and essential fatty acid metabolism in fasting blood samples.37,38 On the other hand, reports from Jongstra et al.23 could be attributed to the small difference of 1 mg/d in zinc intake from the study diet, between the intervention and control arms. The insignificant findings from Shahzad et al.21 were attributed to seasonal changes in dietary intake, especially sources of energy, as indicated by the authors.
Studies exploring changes in enzymatic activity indices of fatty acid metabolism in relation to zinc supplementation have reported mixed results. A recent systematic review and meta-analysis of 21 studies reported no significant mean difference between the intervention and control arms following a Zn intervention in FADS1, indicating that these markers are not very sensitive to changes in dietary zinc intake attained through the introduction of biofortified staples.39
Another putative marker used in the included studies was DNA breaks resulting from oxidative stress.25 Zinc is known to be an important component of many proteins that play a crucial role in defense against free radicals and repair of DNA damage. Cellular ZD can increase oxidative stress, impair the DNA binding activity of p53, and interfere with its function in DNA repair.40,41 ZD can also cause direct DNA damage.42 Human studies involving zinc depletion and repletion have also shown that depletion is associated with increased strand breaks in white blood cells, which are reversible by repletion.43,44 However, in our included study, Signorell et al.25 did not report any difference in olive tail moments, which indicate DNA damage, between the different arms. Further, DNA damage was not associated with PZC. This result could be due to the low difference in zinc intake between the study arms (1.8-3.3 mg/d between biofortified wheat and control wheat), the form of zinc (dietary zinc instead of supplementation), the low sample size (14-21 samples in each arm), or the low prevalence of ZD among the study participants (12%). Previous studies that elicited a response were either depletion repletion studies43,44 or supplementation studies,45 indicating that this marker might only be responsive to supplementary forms of zinc or marked changes in dietary zinc.
Other potential zinc markers, reported by Shahzad et al.,21 are oxylipins, which are important mediators of cellular inflammatory responses and are also linked with noncommunicable diseases.46,47 Although Shahzad et al.21 reported a reduction in pro-inflammatory oxylipins over time, the significant intervention effect was abolished after statistical corrections. Despite a previous trial that has reported a reduction in proinflammatory oxylipins after zinc repletion,48 the mechanistic pathways are still unclear, rendering the practical application of these markers improbable.
Frederickson et al.20 reported HZC indicated by “zinc counts,” and this study is the only investigation included in this review to reveal a positive effect of a biofortified staple crop on zinc status at the endpoint. HZC has been labeled as a “potential zinc biomarker” in a review article.2 The HZC acts as a storage biomarker and reflects zinc uptake by the hair follicles in 4-8 weeks before sample collection.49 Hence it is not surprising that Frederickson et al.20 reported positive changes in the hair zinc count of the participants in the intervention arm, who received 1.5 mg of additional zinc for 25 weeks through biofortified wheat as part of the trial conducted by Gupta et al.22 Supplementation trials have shown similar findings. For example, a systematic review conducted by Lowe et al. included 3 supplementation trials, and the pooled effect size (95% CI) of HZC between the intervention and control arms was 13.24 (11.91-14.56).50 Contrary to these findings, a study among Laotian children did not find any significant difference in HZC as a result of supplementation, although there was a change in PZC and nail zinc concentration (NZC),51 the latter being another “storage marker” labeled as an emerging biomarker of zinc nutrition. The major caveat is that there are no universally accepted reference values for HZC or NZC, limiting the application of these biomarkers in the population. Hence, there is an urgent need to compile a set of universal reference values for hair, fingernail, and toenail zinc concentrations. With these data, the feasibility of employing HZC or NZC to assess the risk of ZD in future intervention trials or national surveys could be explored.49
Since biofortified staples are dietary interventions, interpretation of the results requires accurate information on the intake of zinc from the study diet, that is, biofortified staples. The included studies measured the zinc concentration of biofortified staples to estimate the average zinc intake in the intervention and control arms. However, studies included in this review measured the zinc content of raw cereals. For example, Jongstra et al.23 reported zinc intake from the study rice based on the raw rice zinc content and did not take into consideration the significant loss of zinc that occurs during the process of cooking or that different steps in the cooking process (washing, soaking, and decanting after cooking) determine the amount of zinc loss from raw rice, as seen in previous research.52–56 However, we also acknowledge that the majority of the evidence mentioned above was generated from fortified or conventional cereal and not from biofortified cereal, requiring further research in this aspect. In terms of biofortified wheat, Lowe et al.24 measured the zinc content of wheat grains (49.3 vs 22.2 mg/kg in intervention and control, respectively) and estimated that the difference in zinc intake between the intervention and control groups was 3.0-6.0 mg/d, depending on the level of bran removed from the grain to make bread. However, during the milling process, a significant amount of zinc was lost, as observed in a later study22 that was also included in our review. This study showed that the zinc contents of wheat flour were 20.7 mg/kg and 17.0 mg/kg for the intervention and controls, respectively.22 Thus, zinc intake reported by Lowe et al. was an overestimation that was reduced to half (1.5 mg/d) in the study conducted by Gupta et al., rendering the interpretation of the treatment effect inaccurate.22,24 Therefore, measuring the zinc content of biofortified cereal from a cooked meal will allow future studies to estimate zinc intake more accurately by considering the loss of zinc during the cooking and processing of staples, especially for rice.
Another important aspect of dietary intervention is the consideration of zinc intake from a habitual diet and its bioavailability. The bioavailability and absorption of zinc depends on several factors, such as the phytate content of the diet, which can be later transformed into the phytate zinc molar ratio (PZMR), the presence of iron and copper, and the type of diet (animal or plant source).2 Without data on usual dietary intake, it is difficult to estimate the total zinc intake of study participants and interpret the treatment effect. None of the included studies adjusted their treatment effect for the PZMR of habitual diets. Jongstra et al.23 did not collect data on participants’ usual diets to account for other sources of zinc intake; instead, these investigators only reported the zinc and phytate contents of the study rice varieties. However, since the participants in this study were children 12-18 months old, this omission may be of lesser significance, because the modeling of data conducted by Miller et al. from several absorption studies suggests that, unlike adults, infants and young children experience minimal or no inhibitory effect of phytate on zinc absorption.57 Lowe et al.24 estimated the zinc and phytate content from habitual/usual dietary intake and calculated the PZMR, but they did not control for the confounding effect of PZMR on the treatment effect. As there were some absolute differences in phytate content and PZMR at different time points and between the 2 treatment groups, although not significant, controlling the effect of PZMR may have improved the precision of the treatment effect estimation. Later, using the same wheat varieties in an effectiveness trial, Gupta et al.22 reported the average phytate intake from a habitual/usual diet without comparing the treatment groups. Moreover, these investigators did not calculate the PZMR or bioavailability or consider the effect of PZMR while assessing the treatment effect. Additionally, Gupta et al.22 did not provide any data on the phytate content in their interventional wheat flour. Sazawal et al.26 did not report the zinc and phytate contents of their studied wheat, and collected dietary data only in a subsample, but did not present the data. Sazawal et al.26 also did not calculate the PZMR, bioavailability analysis, or its impact on the treatment effect. Future RCTs on biofortified crops should include detailed dietary information collected from study participants and estimate their habitual intake of zinc and its bioavailability along with those of the study diet.
Some of our included articles were effectiveness trials22 or large-scale trials,26 which made it difficult to exercise close supervision of the implementation of the intervention. Yet strict monitoring of the consumption of the study diet is crucial for accurate estimation of zinc intake. Some of the included studies had a compliance monitoring system that would have rendered inaccurate intake data. For example, Jongstra et al.23 provided weighted cooked rice and measured any leftovers to estimate the rice intake; however, these investigators did not consider that the rice provided could be shared with family members, including siblings, especially when cooked rice was only provided to the study participants. This situation could have led to further overestimation of zinc intake among study participants from the biofortified and control staples.23 In contrast, Lowe et al.24 provided flour for the entire household and considered the number of meals when the study flour was not used. While providing the entire household with study flour is an acceptable approach to prevent “diffusion” among the family members, measuring the actual amount of staple intake would have provided more accurate data. Sazawal et al.26 used a pictorial card to record the portion size of meals consumed by participants. Therefore, a combination of these approaches, that is, providing a supply for the whole family and collecting consumption data from the participants with a pictorial card, would be a more accurate way of monitoring compliance and estimating the actual intake of zinc and other nutrients from the biofortified staple.
Finally, estimation of the zinc intake from biofortified staples has shown that in some cases the incremental zinc is very small. This disadvantage becomes more profound when coupled with loss of zinc during cooking/processing. To mitigate this effect, efforts should be made to increase the zinc content of biofortified crops. Currently several international projects are working on zinc biofortification of different staples. The International HarvestPlus, one of such projects, set the target of 28 µg of zinc per gram of dry matter for polished rice. For wheat it is 38 µg/g of wheat grain and for pearl millet the target is set at 66 mg/kg.6 However, these estimates may be considered somewhat conservative, as the zinc content of the intervention varieties used in some of our included studies have already exceeded this amount. Considering the possibilities of significant zinc loss during the processing and cooking of cereals, along with the low bioavailability caused by the presence of phytate, plant breeders and breeding centers should aim to develop biofortified crops with higher levels of zinc concentration. With integrated agronomic and breeding approaches. crop zinc concentrations can reach levels that meet human nutritional requirements.
There are some limitations to this review. A limited number of articles matched our inclusion criteria, and the methodological and analytical flaws of the included articles made it difficult to draw conclusions regarding the efficacy of the biofortified staple in improving zinc status. However, the strength of this review is that all of our included articles were RCTs, which generate very high levels of evidence. Moreover, most of the included articles explored markers of zinc status other than PZC, which serves as valuable evidence in identifying a suitable biomarker for zinc status in the population.
CONCLUSION
This is to our knowledge the first systematic review article on the efficacy of biofortified staples in improving zinc status, which reveals that PZC, the most reliable population-level biomarker of zinc status, remains largely unaffected by the consumption of biofortified staple crops. However, our analysis had several methodological and analytical limitations. Addressing these issues in future research is crucial to accurately determine the efficacy of zinc-biofortified staple crops in improving the zinc status across population groups.
Supplementary Material
Acknowledgements
The authors thank Heather Monro-Allison of Griffith University Library for her assistance during the literature search for this review.
Contributor Information
Prasenjit Mondal, Public Health, School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia; BRAC James P Grant School of Public Health, BRAC University, Dhaka 1213, Bangladesh.
Satyajit Kundu, Public Health, School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia.
Hai N Phung, Public Health, School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia.
Sabuktagin Rahman, Department of Public Health, Faculty of Arts and Social Sciences, American International University-Bangladesh, Dhaka 1229, Bangladesh.
Malay K Mridha, BRAC James P Grant School of Public Health, BRAC University, Dhaka 1213, Bangladesh; Center for Non-communicable Diseases and Nutrition, BRAC James P Grant School of Public Health, BRAC University, Dhaka 1213, Bangladesh.
Faruk Ahmed, Public Health, School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia.
Author Contributions
P.M., H.N.P., and F.A. conceptualized the study. P.M. performed the literature search. P.M. and S.K. performed the article screening, data extraction, and interpretation. P.M. and S.K. wrote the article with feedback for revision from S.R., M.K.M., H.N.P., and F.A. All authors contributed to the final approval of the version to be published.
Supplementary Material
Supplementary Material is available at Nutrition Reviews online.
Funding
No financial support was provided for this study.
Conflicts of Interest
The authors declare that they have no conflict of interest.
References
- 1. Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One. 2012;7:e50568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. King JC, Brown KH, Gibson RS, et al. Biomarkers of nutrition for development (BOND)—zinc review. J Nutr. 2015;146:858S-885S. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Caulfield LE, Zavaleta N, Shankar AH, Merialdi M. Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr. 1998;68:499S-508S. [DOI] [PubMed] [Google Scholar]
- 4. Prasad AS. Zinc deficiency in women, infants and children. J Am Coll Nutr. 1996;15:113-120. [DOI] [PubMed] [Google Scholar]
- 5. Gupta S, Brazier A, Lowe N. Zinc deficiency in low‐and middle‐income countries: prevalence and approaches for mitigation. J Hum Nutr Diet. 2020;33:624-643. [DOI] [PubMed] [Google Scholar]
- 6. Bouis HE, Saltzman A. Improving nutrition through biofortification: a review of evidence from HarvestPlus, 2003 through 2016. Glob Food Sec. 2017;12:49-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Andersson MS, Saltzman A, Virk PS, Pfeiffer WH. Progress update: crop development of biofortified staple food crops under HarvestPlus. Afr J Food Agric Nutr Dev. 2017;17:11905-11935. [Google Scholar]
- 8. Brnić M, Wegmüller R, Melse-Boonstra A, et al. Zinc absorption by adults is similar from intrinsically labeled zinc-biofortified rice and from rice fortified with labeled zinc sulfate. J Nutr. 2016;146:76-80. [DOI] [PubMed] [Google Scholar]
- 9. Chomba E, Westcott CM, Westcott JE, et al. Zinc absorption from biofortified maize meets the requirements of young rural Zambian children. J Nutr. 2015;145:514-519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kodkany BS, Bellad RM, Mahantshetti NS, et al. Biofortification of pearl millet with iron and zinc in a randomized controlled trial increases absorption of these minerals above physiologic requirements in young children. J Nutr. 2013;143:1489-1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Signorell C, Zimmermann MB, Cakmak I, et al. Zinc absorption from agronomically biofortified wheat is similar to post-harvest fortified wheat and is a substantial source of bioavailable zinc in humans. J Nutr. 2019;149:840-846. [DOI] [PubMed] [Google Scholar]
- 12. Liong EM, McDonald CM, Suh J, et al. Zinc-biofortified wheat intake and zinc status biomarkers in men: randomized controlled trial. J Nutr. 2021;151:1817-1823. [DOI] [PubMed] [Google Scholar]
- 13. Rosado JL, Hambidge KM, Miller LV, et al. The quantity of zinc absorbed from wheat in adult women is enhanced by biofortification. J Nutr. 2009;139:1920-1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Gomes MJC, Martino HSD, Tako E. Zinc-biofortified staple food crops to improve zinc status in humans: a systematic review. Crit Rev Food Sci Nutr. 2023;63:4966-4978. [DOI] [PubMed] [Google Scholar]
- 15. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Mondal P, Kundu S, Rahman S, Phung H, Mridha MK, Ahmed F. Efficacy or effectiveness of zinc biofortified staples in improving biomarkers of zinc status: a systematic review. PROSPERO. https://www.crd.york.ac.uk/PROSPERO/view/CRD42025603758 [DOI] [PMC free article] [PubMed]
- 17. All Clinical Trials—Scopus. In: Canada’s Drug Agency Search Filters Database. Ottawa, ON: Canada’s Drug Agency; 2025. Accessed August 10, 2025. https://searchfilters.cda-amc.ca/link/106
- 18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12. [DOI] [PubMed] [Google Scholar]
- 19. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Frederickson CJ, Fleming DE, Asael D, et al. Single hair analysis by X-ray fluorescence spectrometry detects small changes in dietary zinc intake: a nested randomized controlled trial. Front Nutr. 2023;10:1139017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Shahzad B, Holt RR, Gupta S, et al. Effects of zinc-biofortified wheat intake on plasma markers of fatty acid metabolism and oxidative stress among adolescents. Nutrients. 2024;16:4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Gupta S, Zaman M, Fatima S, et al. The impact of consuming zinc-biofortified wheat flour on haematological indices of zinc and iron status in adolescent girls in rural Pakistan: a cluster-randomised, double-blind, controlled effectiveness trial. Nutrients. 2022;14:1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Jongstra R, Hossain MM, Galetti V, et al. The effect of zinc-biofortified rice on zinc status of Bangladeshi preschool children: a randomized, double-masked, household-based, controlled trial. Am J Clin Nutr. 2022;115:724-737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Lowe NM, Zaman M, Khan MJ, et al. Biofortified wheat increases dietary zinc intake: a randomised controlled efficacy study of zincol-2016 in Rural Pakistan. Front Nutr. 2022;8:809783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Signorell C, Kurpad AV, Pauline M, et al. The effect of zinc biofortified wheat produced via foliar application on zinc status: a randomized, controlled trial in Indian children. J Nutr. 2023;153:3092-3100. [DOI] [PubMed] [Google Scholar]
- 26. Sazawal S, Dhingra U, Dhingra P, et al. Efficacy of high zinc biofortified wheat in improvement of micronutrient status, and prevention of morbidity among preschool children and women-a double masked, randomized, controlled trial. Nutr J. 2018;17:86-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. King JC. Assessment of zinc status. J Nutr. 1990;120(suppl 11):1474-1479. [DOI] [PubMed] [Google Scholar]
- 28. Hambidge KM, Hambidge C, Jacobs M, Baum JD. Low levels of zinc in hair, anorexia, poor growth, and hypogeusia in children. Pediatr Res. 1972;6:868-874. [DOI] [PubMed] [Google Scholar]
- 29. Walravens PA, Hambidge KM. Growth of infants fed a zinc supplemented formula. Am J Clin Nutr. 1976;29:1114-1121. [DOI] [PubMed] [Google Scholar]
- 30. Walravens PA, Hambidge KM, Koepfer DM. Zinc supplementation in infants with a nutritional pattern of failure to thrive: a double-blind, controlled study. Pediatrics. 1989;83:532-538. [PubMed] [Google Scholar]
- 31. Walravens PA, Krebs NF, Hambidge KM. Linear growth of low income preschool children receiving a zinc supplement. Am J Clin Nutr. 1983;38:195-201. [DOI] [PubMed] [Google Scholar]
- 32. Ayala S, Brenner RR. Essential fatty acid status in zinc deficiency. Effect on lipid and fatty acid composition, desaturation activity and structure of microsomal membranes of rat liver and testes. Acta Physiol Lat Am. 1983;33:193-204. [PubMed] [Google Scholar]
- 33. Horrobin D, Cunnane S. Interactions between zinc, essential fatty acids and prostaglandins: relevance to acrodermatitis enteropathica, total parenteral nutrition, the glucagonoma syndrome, diabetes, anorexia nervosa and sickle cell anaemia. Med Hypotheses. 1980;6:277-296. [DOI] [PubMed] [Google Scholar]
- 34. Knez M, Stangoulis JC, Zec M, et al. An initial evaluation of newly proposed biomarker of zinc status in humans-linoleic acid: dihomo-γ-linolenic acid (LA: DGLA) ratio. Clin Nutr ESPEN. 2016;15:85-92. [DOI] [PubMed] [Google Scholar]
- 35. Nakamura MT, Nara TY. Structure, function, and dietary regulation of Δ6, Δ5, and Δ9 desaturases. Annu Rev Nutr. 2004;24:345-376. [DOI] [PubMed] [Google Scholar]
- 36. Clejan S, Castro‐Magana M, Collipp PJ, Jonas E, Maddaiah VT. Effects of zinc deficiency and castration on fatty acid composition and desaturation in rats. Lipids. 1982;17:129-135. [DOI] [PubMed] [Google Scholar]
- 37. Chimhashu T, Malan L, Baumgartner J, et al. Sensitivity of fatty acid desaturation and elongation to plasma zinc concentration: a randomised controlled trial in Beninese children. Br J Nutr. 2018;119:610-619. [DOI] [PubMed] [Google Scholar]
- 38. Hernández MC, Rojas P, Carrasco F, et al. Fatty acid desaturation in red blood cell membranes of patients with type 2 diabetes is improved by zinc supplementation. J Trace Elem Med Biol. 2020;62:126571. [DOI] [PubMed] [Google Scholar]
- 39. Knez M, Pantovic A, Tako E, Boy E. FADS1 and FADS2 as biomarkers of Zn status–a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2024;64:3187-3205. [DOI] [PubMed] [Google Scholar]
- 40. Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci U S A. 2002;99:16770-16775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Oteiza PI, Clegg MS, Keen CL. Short-term zinc deficiency affects nuclear factor-κB nuclear binding activity in rat testes. J Nutr. 2001;131:21-26. [DOI] [PubMed] [Google Scholar]
- 42. Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem. 2004;15:572-578. [DOI] [PubMed] [Google Scholar]
- 43. Song Y, Chung CS, Bruno RS, et al. Dietary zinc restriction and repletion affects DNA integrity in healthy men. Am J Clin Nutr. 2009;90:321-328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Zyba SJ, Shenvi SV, Killilea DW, et al. A moderate increase in dietary zinc reduces DNA strand breaks in leukocytes and alters plasma proteins without changing plasma zinc concentrations. Am J Clin Nutr. 2017;105:343-351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Sharif R, Thomas P, Zalewski P, Fenech M. Zinc supplementation influences genomic stability biomarkers, antioxidant activity, and zinc transporter genes in an elderly Australian population with low zinc status. Mol Nutr Food Res. 2015;59:1200-1212. [DOI] [PubMed] [Google Scholar]
- 46. Morris JK, Piccolo BD, John CS, Green ZD, Thyfault JP, Adams SH. Oxylipin profiling of Alzheimer’s disease in nondiabetic and type 2 diabetic elderly. Metabolites. 2019;9:177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Nayeem MA. Role of oxylipins in cardiovascular diseases. Acta Pharmacol Sin. 2018;39:1142-1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Suh JH, Zyba SJ, Shigenaga M, McDonald CM, King JC. Marginal zinc deficiency alters essential fatty acid metabolism in healthy men. J Nutr. 2022;152:671-679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Gibson R. IZiNCG Technical Brief No. 8: assessing population zinc exposure with hair or nail zinc.: IZiNCG; 2018.
- 50. Lowe NM, Fekete K, Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr. 2009;89:2040S-2051S. [DOI] [PubMed] [Google Scholar]
- 51. Wessells KR, Brown KH, Arnold CD, et al. Plasma and nail zinc concentrations, but not hair zinc, respond positively to two different forms of preventive zinc supplementation in young laotian children: a randomized controlled trial. Biol Trace Elem Res. 2021;199:442-452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Azam MM, Padmavathi S, Fiyaz RA, Waris A, Ramya K, Neeraja CN. Effect of different cooking methods on loss of iron and zinc micronutrients in fortified and non-fortified rice. Saudi J Biol Sci. 2021;28:2886-2894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Liu K, Zheng J, Wang X, Chen F. Effects of household cooking processes on mineral, vitamin B, and phytic acid contents and mineral bioaccessibility in rice. Food Chem. 2019;280:59-64. [DOI] [PubMed] [Google Scholar]
- 54. Mwale T, Rahman MM, Mondal D. Risk and benefit of different cooking methods on essential elements and arsenic in rice. Int J Environ Res Public Health. 2018;15:1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Norhaizan M, Nor Faizadatul Ain A. Determination of phytate, iron, zinc, calcium contents and their molar ratios in commonly consumed raw and prepared food in Malaysia. Malays J Nutr. 2009;15:213-222. [PubMed] [Google Scholar]
- 56. Thomas AO, Olayinka A, Kayode A. Comparative study of nutrient composition and retention of raw and cooked imported and local rice (Oryza sativa) varieties. BJAST. 2016;16:1-9. [Google Scholar]
- 57. Miller LV, Hambidge KM, Krebs NF. Zinc absorption is not related to dietary phytate intake in infants and young children based on modeling combined data from multiple studies. J Nutr. 2015;145:1763-1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
